MOGRIFY
Live / Registered — Registered (as of 27 Jul 2021)
What this means for you
Registered since 27 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79289697
- Registration number
- 6430514
- Mark type
- Stylized text
- Filed
- 13 May 2020
- Published for opposition
- 11 May 2021
- Registered
- 27 Jul 2021
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
- Class 005 — Pharmaceuticals: Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical and biopharmaceutical preparations for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; pharmaceutical and biopharmaceutical preparations for cell therapy; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; biological, chemical and biochemical reagents for medical use
- Class 009 — Scientific and electric apparatus: Downloadable bioinformatics software for genomic data analysis; downloadable computer software platforms for genomic data analysis in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; scientific apparatus for measuring and analysing scientific study data in the nature of apparatus for recording, transmission or reproduction of data including video, audio, images and text; data analysis apparatus in the nature of data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
- Class 040 — Treatment of materials: Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs, namely custom manufacture of transcription factors, cells and cell therapies, gene therapies ; information, advisory and consultancy services in relation to all of the aforesaid services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services in the field of cell therapies and gene therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; software as a service (SaaS) services featuring software for use in genomic data analysis; platform as a service (Paas) services that feature a computer bioinformatics platform for use in manufacturing therapeutics; providing a bioinformatics platform for identifying transcription factors to turn one cell type into another cell type; advisory and consultancy relating to all the aforesaid services
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of manipulation of human and animal cells for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
Owner
- Mogrify Limited, GB
- Mogrify Limited, GB
- Mogrify Limited, GB
Prosecution history
- 04 Jan 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Dec 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Dec 2021 — FINAL DISPOSITION PROCESSED
- 27 Oct 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2021 — NOTIFICATION PROCESSED BY IB
- 11 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 May 2021 — PUBLISHED FOR OPPOSITION
- 21 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 21 Apr 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 21 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Apr 2021 — EXAMINER'S AMENDMENT ENTERED
- 02 Apr 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Apr 2021 — EXAMINERS AMENDMENT E-MAILED